{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:21:53Z","timestamp":1779294113046,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00428-023-03684-6","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T08:02:42Z","timestamp":1699084962000},"page":"481-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["STAT expression and TFH1 cells in CVID granulomatosis and sarcoidosis: immunological and histopathological comparisons"],"prefix":"10.1007","volume":"484","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-9323","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Viallard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00eblig","family":"Lescure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Oksenhendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"key":"3684_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","volume":"35","author":"C Picard","year":"2015","unstructured":"Picard C, Al-Herz W, Bousfiha A et al (2015) Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol 35:696\u2013726","journal-title":"J Clin Immunol"},{"key":"3684_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","volume":"34","author":"L Kobrynski","year":"2014","unstructured":"Kobrynski L, Powell RW, Bowen S (2014) Prevalence and morbidity of primary immunodeficiency diseases, United States 2001\u20132007. J Clin Immunol 34:954\u2013961","journal-title":"J Clin Immunol"},{"key":"3684_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M et al (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112:277\u2013286","journal-title":"Blood"},{"key":"3684_CR4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","volume":"119","author":"ES Resnick","year":"2012","unstructured":"Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C (2012) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119:1650\u20131657","journal-title":"Blood"},{"key":"3684_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","volume":"11","author":"HE Ho","year":"2020","unstructured":"Ho HE, Cunningham-Rundles C (2020) Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis. Front Immunol 11:149. https:\/\/doi.org\/10.3389\/fimmu.2020.00149","journal-title":"Front Immunol"},{"key":"3684_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1183\/09031936.00189011","volume":"41","author":"D Bouvry","year":"2013","unstructured":"Bouvry D, Mouthon L, Brillet P-Y et al (2013) Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J 41:115\u2013122","journal-title":"Eur Respir J"},{"key":"3684_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00005792-199609000-00002","volume":"75","author":"MB Fasano","year":"1996","unstructured":"Fasano MB, Sullivan KE, Sarpong SB et al (1996) Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75:251\u2013261","journal-title":"Medicine (Baltimore)"},{"key":"3684_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1055\/s-0034-1376862","volume":"35","author":"JW Verbsky","year":"2014","unstructured":"Verbsky JW, Routes JM (2014) Sarcoidosis and common variable immunodeficiency: similarities and differences. Semin Respir Crit Care Med 35:330\u2013335","journal-title":"Semin Respir Crit Care Med"},{"key":"3684_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","volume":"13","author":"A Mannina","year":"2016","unstructured":"Mannina A, Chung JH, Swigris JJ et al (2016) Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease. Ann Am Thorac Soc 13:1042\u20131049","journal-title":"Ann Am Thorac Soc"},{"key":"3684_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/0003-4819-127-8_Part_1-199710150-00005","volume":"127","author":"LJ Mechanic","year":"1997","unstructured":"Mechanic LJ, Dikman S, Cunningham-Rundles C (1997) Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127:613\u2013617","journal-title":"Ann Intern Med"},{"key":"3684_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s11882-005-0008-x","volume":"5","author":"Y Morimoto","year":"2005","unstructured":"Morimoto Y, Routes JM (2005) Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 5:370\u2013375","journal-title":"Curr Allergy Asthma Rep"},{"key":"3684_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","volume":"133","author":"\u00d6 Ardeniz","year":"2009","unstructured":"Ardeniz \u00d6, Cunningham-Rundles C (2009) Granulomatous disease in common variable immunodeficiency. Clin Immunol 133:198\u2013207","journal-title":"Clin Immunol"},{"key":"3684_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","volume":"33","author":"JN Boursiquot","year":"2013","unstructured":"Boursiquot JN, G\u00e9rard L, Malphettes M et al (2013) Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 33:84\u201395","journal-title":"J Clin Immunol"},{"key":"3684_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/PAS.0000000000000661","volume":"40","author":"A Furudo\u00ef","year":"2016","unstructured":"Furudo\u00ef A, Gros A, Stanislas S et al (2016) Spleen histologic appearance in common variable immunodeficiency: analysis of 17 cases. Am J Surg Pathol 40:958\u2013967","journal-title":"Am J Surg Pathol"},{"key":"3684_CR15","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1086\/587669","volume":"46","author":"E Oksenhendler","year":"2008","unstructured":"Oksenhendler E, Gerard L, Fieschi C et al (2008) Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 46:1547\u20131554","journal-title":"Clin Infect Dis"},{"key":"3684_CR16","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","volume":"7","author":"MG Seidel","year":"2019","unstructured":"Seidel MG, Kindle G, Gathmann B et al (2019) The European Society for Immunodeficiencies (ESID) Registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract 7:1763\u20131770","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3684_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOGD) adopted by the ATS Board of Directors and by the ERS Executive Committee","year":"1999","unstructured":"Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOGD) adopted by the ATS Board of Directors and by the ERS Executive Committee (1999) Statement on sarcoidosis. Am J Respir Crit Care Med 160:736\u2013755","journal-title":"Am J Respir Crit Care Med"},{"key":"3684_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C et al (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111:77\u201385","journal-title":"Blood"},{"key":"3684_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.clim.2018.09.006","volume":"197","author":"D Turpin","year":"2018","unstructured":"Turpin D, Furudo\u00ef A, Parrens M, Blanco P, Viallard JF, Duluc D (2018) Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications. Clin Immunol 197:130\u2013138","journal-title":"Clin Immunol"},{"key":"3684_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.clim.2008.03.510","volume":"128","author":"DF Arnold","year":"2008","unstructured":"Arnold DF, Arnold DF, Wiggins J, Cunningham-Rundles C, Misbah SA, Chapel HM (2008) Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol 128:18\u201322","journal-title":"Clin Immunol"},{"key":"3684_CR21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1183\/09031936.00025513","volume":"43","author":"F Kollert","year":"2014","unstructured":"Kollert F, Venhoff N, Goldacker S et al (2014) Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID. Eur Respir J 43:922\u2013924","journal-title":"Eur Respir J"},{"key":"3684_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clim.2005.11.011","volume":"119","author":"JF Viallard","year":"2006","unstructured":"Viallard JF, Blanco P, Andr\u00e9 M et al (2006) CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin Immunol 119:51\u201358","journal-title":"Clin Immunol"},{"key":"3684_CR23","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","volume":"178","author":"A Giovannetti","year":"2007","unstructured":"Giovannetti A, Pierdominici M, Mazzetta F et al (2007) Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 178:3932\u20133943","journal-title":"J Immunol"},{"key":"3684_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2249.2012.04643.x","volume":"170","author":"EA Bateman","year":"2012","unstructured":"Bateman EA, Ayers L, Sadler R et al (2012) T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 170:202\u2013211","journal-title":"Clin Exp Immunol"},{"key":"3684_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.rinim.2013.05.004","volume":"3","author":"JF Viallard","year":"2013","unstructured":"Viallard JF, Ruiz C, Guillet M, Pellegrin JL, Moreau JF (2013) Perturbations of the CD8(+) T-cell repertoire in CVID patients with complications. Results Immunol 3:122\u2013128","journal-title":"Results Immunol"},{"key":"3684_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2172-15-13","volume":"15","author":"MQ Picat","year":"2014","unstructured":"Picat MQ, Thi\u00e9baut R, Lifermann F et al (2014) T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults. BMC Immunol 15:13. https:\/\/doi.org\/10.1186\/1471-2172-15-13","journal-title":"BMC Immunol"},{"key":"3684_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5858\/arpa.2020-0543-RA","volume":"146","author":"Y Rosen","year":"2022","unstructured":"Rosen Y (2022) Pathology of granulomatous pulmonary diseases. Arch Pathol Lab Med 146:233\u2013251","journal-title":"Arch Pathol Lab Med"},{"key":"3684_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jaci.2020.01.046","volume":"146","author":"J Hultberg","year":"2020","unstructured":"Hultberg J, Ernerudh J, Larsson M, Nilsdotter-Augustinsson \u00c5, Nystr\u00f6m S (2020) Plasma protein profiling reflects TH1-driven immune dysregulation in common variable immunodeficiency. J Allergy Clin Immunol 146:417\u2013428","journal-title":"J Allergy Clin Immunol"},{"key":"3684_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149480","author":"G Milardi","year":"2022","unstructured":"Milardi G, Di Lorenzo B, Gerosa J et al (2022) Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency. Eur J Immunol. https:\/\/doi.org\/10.1002\/eji.202149480","journal-title":"Eur J Immunol"},{"key":"3684_CR30","doi-asserted-by":"publisher","first-page":"616832","DOI":"10.3389\/fimmu.2020.616832","volume":"11","author":"D Friedmann","year":"2021","unstructured":"Friedmann D, Unger S, Keller B et al (2021) Bronchoalveolar lavage fluid reflects a TH1-CD21low B-cell interaction in CVID-related interstitial lung disease. Front Immunol 11:616832. https:\/\/doi.org\/10.3389\/fimmu.2020.616832","journal-title":"Front Immunol"},{"key":"3684_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","volume":"132","author":"JT Rosenbaum","year":"2009","unstructured":"Rosenbaum JT, Pasadhika S, Crouser ED et al (2009) Hypothesis: sarcoidosis is a STAT1-mediated disease. Clin Immunol 132:174\u2013183","journal-title":"Clin Immunol"},{"key":"3684_CR32","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1038\/s41598-017-04109-6","volume":"7","author":"T Zhou","year":"2017","unstructured":"Zhou T, Casanova N, Pouladi N et al (2017) Identification of JAK-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature. Sci Rep 7:4237. https:\/\/doi.org\/10.1038\/s41598-017-04109-6","journal-title":"Sci Rep"},{"key":"3684_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.gene.2016.09.037","volume":"596","author":"H Li","year":"2017","unstructured":"Li H, Zhao X, Wang J, Zong M, Yang H (2017) Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis. Gene 596:98\u2013104","journal-title":"Gene"},{"key":"3684_CR34","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","volume":"379","author":"W Damsky","year":"2018","unstructured":"Damsky W, Thakral D, Emeagwali N et al (2018) Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis. N Engl J Med 379:2540\u20132546","journal-title":"N Engl J Med"},{"key":"3684_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/acr2.11112","volume":"2","author":"W Damsky","year":"2020","unstructured":"Damsky W, Young BD, Sloan B et al (2020) Treatment of multiorgan sarcoidosis with tofacitinib. ACR Open Rheumatol 2:106\u2013109","journal-title":"ACR Open Rheumatol"},{"key":"3684_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jdcr.2021.08.012","volume":"16","author":"R Talty","year":"2021","unstructured":"Talty R, Damsky W, King B (2021) Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis. JAAD Case Rep 16:62\u201364","journal-title":"JAAD Case Rep"},{"key":"3684_CR37","doi-asserted-by":"publisher","first-page":"606099","DOI":"10.3389\/fimmu.2021.606099","volume":"12","author":"OAC Lamers","year":"2021","unstructured":"Lamers OAC, Smits BM, Leavis HL et al (2021) Treatment strategies for GLILD in common variable immunodeficiency: a systematic review. Front Immunol 12:606099. https:\/\/doi.org\/10.3389\/fimmu.2021.606099","journal-title":"Front Immunol"},{"key":"3684_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2016.11.002","volume":"175","author":"TH Scott-Taylor","year":"2017","unstructured":"Scott-Taylor TH, Whiting K, Pettengell R, Webster DA (2017) Enhanced formation of giant cells in common variable immunodeficiency: relation to granulomatous disease. Clin Immunol 175:1\u20139","journal-title":"Clin Immunol"},{"key":"3684_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2165\/00063030-200317060-00005","volume":"17","author":"RP Baughman","year":"2003","unstructured":"Baughman RP, Iannuzzi M (2003) Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs 17:425\u2013431","journal-title":"BioDrugs"},{"key":"3684_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","volume":"87","author":"P Aukrust","year":"1996","unstructured":"Aukrust P, Lien E, Kristoffersen AK et al (1996) Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2014possible immunologic and clinical consequences. Blood 87:674\u2013681","journal-title":"Blood"},{"key":"3684_CR41","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.4049\/jimmunol.159.12.6236","volume":"159","author":"CG Mullighan","year":"1997","unstructured":"Mullighan CG, Fanning GC, Chapel HM, Welsh KI (1997) TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 159:6236\u20136241","journal-title":"J Immunol"},{"key":"3684_CR42","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s10875-014-0079-3","volume":"34","author":"TJ Franxman","year":"2014","unstructured":"Franxman TJ, Howe LE, Baker JR (2014) Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency. J Clin Immunol 34:820\u2013827","journal-title":"J Clin Immunol"},{"key":"3684_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12931-022-01971-5","volume":"23","author":"A Sakkat","year":"2022","unstructured":"Sakkat A, Cox G, Khalidi N et al (2022) Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis. Respir Res 23:54","journal-title":"Respir Res"},{"key":"3684_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10875-016-0234-0","volume":"36","author":"D Boutboul","year":"2016","unstructured":"Boutboul D, Vince N, Mahevas M et al (2016) TNFA, ANXA11 and BTNL2 polymorphisms in CVID patients with granulomatous disease. J Clin Immunol 36:110\u2013112","journal-title":"J Clin Immunol"},{"key":"3684_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita R, Schmitt N, Bentebibel SE et al (2011) Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108\u2013121","journal-title":"Immunity"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03684-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03684-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:22:14Z","timestamp":1713266534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03684-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3684"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03684-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CVID patients were enrolled in the ALTADIH Cohort which was approved by the Bordeaux University Institutional Review Board on December 20, 2006 (no. 2.04.2007). Each CVID patient gave informed written consent before participating in the study. Retrospective non opposition to participate to the study was obtained from each sarcoidosis patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}